Our mission is to disrupt the field of surgery and positively impact the lives of patients through the development of our platform of biomorphic programmable polymers
A NEW ERA OF RECONSTRUCTIVE POLYMERS
TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures:
To reconstruct damaged tissue and restore its natural function.
TISSUE RECONSTRUCTION
TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function.
POTENTIAL
Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas.
Indie beauty represents the entrepreneurial and innovative spirit pushing the personal care industry forward. According…
KOSÉ Corporation and Tokyo Electron Device Limited will jointly exhibit a “Mixed Reality Makeup 0…
Will the recurring controversies over the actual level of protection that sunscreens provide soon come…